141 related articles for article (PubMed ID: 14139548)
1. EVIDENCE FOR IMMUNOLOGICAL SPECIFICITY OF THE PROPERDIN SYSTEM; DEMONSTRATION, ISOLATION AND PROPERTIES OF A SERUM FACTOR WHICH INTERACTS WITH ZYMOSAN AND OTHER POLYSACCHARIDES AT 0 DEGREES CENTIGRADE.
BLUM L
J Immunol; 1964 Jan; 92():61-72. PubMed ID: 14139548
[No Abstract] [Full Text] [Related]
2. Quantitative studies on the properdin-complement system. II. Kinetics of the reaction between properdin and zymosan.
LEON MA
J Exp Med; 1957 May; 105(5):403-15. PubMed ID: 13428911
[TBL] [Abstract][Full Text] [Related]
3. An alternative mechanism for the properdin system.
NELSON RA
J Exp Med; 1958 Oct; 108(4):515-35. PubMed ID: 13575682
[TBL] [Abstract][Full Text] [Related]
4. The properdin system and immunity. XV. Some biologic effects of the administration of zvmosan and other polvsaccharides to rabbits, and the presence of antibodies to zymosan in human and rabbit serum.
HINZ CF; WEDGWOOD RJ; PILLEMER L
J Lab Clin Med; 1961 Feb; 57():185-98. PubMed ID: 13714488
[No Abstract] [Full Text] [Related]
5. A simple method for isolation of human properdin by affinity chromatography.
Konno T; Hirai H
J Immunol Methods; 1976; 12(1-2):47-55. PubMed ID: 792350
[TBL] [Abstract][Full Text] [Related]
6. [NATURAL INNATE IMMUNITY FOR BRUCELLA MELITENSIS. I. RELATION WITH PROPERDIN, COMPLEMENT, BACTERICIDAL PROPERTIES OF SERUM AND THE FORMATION OF SPECIFIC ANTIBODIES].
LEON AP; OSOLLO G; CANO C
Rev Inst Salubr Enferm Trop; 1962 Dec; 22():145-72. PubMed ID: 14076958
[No Abstract] [Full Text] [Related]
7. Quantitative studies on the properdin-complement system.
LEON MA
J Exp Med; 1956 Mar; 103(3):285-93. PubMed ID: 13295486
[TBL] [Abstract][Full Text] [Related]
8. Quantitative studies of the properdin-complement system. III. Kinetics of the reaction between C'3 and the properdin-zymosan complex.
LEON MA
J Immunol; 1958 Jul; 81(1):23-8. PubMed ID: 13563875
[No Abstract] [Full Text] [Related]
9. The reaction of zymosan with the properdin system in normal and C4-deficienct guinea pig serum. Demonstration of C3- and C5-cleaving multi-unit enzymes, both containing factor B, and acceleration of their formation by the classical complement pathway.
Brade V; Lee GD; Nicholson A; Shin HS; Mayer MM
J Immunol; 1973 Nov; 111(5):1389-400. PubMed ID: 4795621
[No Abstract] [Full Text] [Related]
10. The reaction of zymosan with the properdin system: isolation of purified factor D from guinea pig serum and study of its reaction characteristics.
Brade V; Nicholson A; Lee GD; Mayer MM
J Immunol; 1974 May; 112(5):1845-54. PubMed ID: 4818461
[No Abstract] [Full Text] [Related]
11. The properdin system and immunity. XI. Studies on the interaction of zymosan with the properdin system.
BLUM L; PILLEMER L; LEPOW IH
Z Immun exp ther; 1959; 118():313-28. PubMed ID: 13801695
[No Abstract] [Full Text] [Related]
12. [Interrelations of zymosan, properdin & tumors. III. Behavior of the properdin level in benzopyrene sarcoma-bearing rats treated with zymosan].
FUMAROLA D; MODICA F
Tumori; 1959; 45(1):46-53. PubMed ID: 13659609
[No Abstract] [Full Text] [Related]
13. [Influencing of the serum properdin levels of patients with neoplasms by parenteral administration of zymosan].
SZABO IK
Orv Hetil; 1960 Feb; 101():222-5. PubMed ID: 13836258
[No Abstract] [Full Text] [Related]
14. Research on the properdin system. I. Inactivation of the third complement component through zymosan on inulin.
HEISE ER
Klin Wochenschr; 1958 Jan; 36(2):88-9. PubMed ID: 13540126
[No Abstract] [Full Text] [Related]
15. Alterations in serum lysozyme and properdin titers of mice following x-irradiation or treatment with zymosan or endotoxin.
HOOK WA; CAREY WF; MUSCHEL LH
J Immunol; 1960 Jun; 84():569-75. PubMed ID: 14402997
[No Abstract] [Full Text] [Related]
16. Anaphylatoxin formation by contact activation of plasma. II. Implication of properdin and an unknown plasma factor in activation by zymosan.
Brade V; Vogt W
Eur J Immunol; 1971 Aug; 1(4):295-300. PubMed ID: 4945686
[No Abstract] [Full Text] [Related]
17. The possible role of the properdin system in transplantable cancer; the effect of zymosan on transplantable human carcinoma.
HERBUT PA; KRAEMER WH
Cancer Res; 1956 Dec; 16(11):1048-52. PubMed ID: 13383472
[No Abstract] [Full Text] [Related]
18. [Influence of subcutaneously and intramuscularly administered zymosan on the properdin titer of serum and on leukocyte count in animal experiments].
ZSEBOK Z; WACHTL I; SZY S; SELLEI G
Orv Hetil; 1960 Feb; 101():226-9. PubMed ID: 13847797
[No Abstract] [Full Text] [Related]
19. [The properdin system and its role in infection and immunity. I. The production of active preparations of zymosan].
NIKITINA VD; KHOLCHEV NV; ANDREEVA ZM; SOKHINA AM; CHERNOKHVOSTOVA EV; PLETENEVA IL
Zh Mikrobiol Epidemiol Immunobiol; 1960 Aug; 31():12-9. PubMed ID: 13729079
[No Abstract] [Full Text] [Related]
20. A factor in rheumatoid arthritic sera interfering in the zymosan assay of properdin.
LAURELL AB
Acta Pathol Microbiol Scand; 1959; 45(4):392-400. PubMed ID: 13660839
[No Abstract] [Full Text] [Related]
[Next] [New Search]
